Why does PCOS cause scalp thinning but extra hair elsewhere?

Both come from the same androgen biology. Androgens miniaturise genetically sensitive scalp follicles while stimulating coarser terminal hair on the face and body — too much hair where you do not want it, too little where you do.

What symptoms cluster with PCOS-related hair loss?

Irregular periods, stubborn weight around the midsection, acne that never fully resolved after the teens, unwanted facial hair, and noticeable thinning on the scalp.

Can PCOS hair loss be managed without drugs?

Drug-free routines target the DHT pathway, but PCOS itself is a medical diagnosis with metabolic implications — work with a physician on the underlying condition alongside anything topical or nutritional.

PCOS and Hair Loss: When Your Own Hormones Turn Against Your Follicles

August 9, 2026

Clinical science of MD Nutri Hair — lilac stem cell extract standardized for verbascoside

By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc. — Hormonal & Life Stage Hair Loss Series

You may have been told you have polycystic ovary syndrome — PCOS — years ago. Or you may be sitting with a cluster of symptoms you've never had a name for: irregular periods, stubborn midsection weight, adult acne, unwanted facial hair — and now, hair that is noticeably thinning on your scalp.

The bitter paradox of PCOS is something many women describe with raw frustration: too much hair where you don't want it, and not enough where you need it most.

That paradox is not random. It is the androgen biology of PCOS — and understanding it is the first step toward doing something meaningful about the hair side of it. One rule first: PCOS is a medical condition, diagnosed and managed by your physician. Nothing we make treats PCOS. What a drug-free routine can do is help address some of the hair concerns associated with it — and this article is honest about where that line sits.

What PCOS Is — and How Common

PCOS is the most common endocrine disorder of reproductive-age women, affecting an estimated 8–13% — with a large share undiagnosed (March et al., Human Reproduction, 2010). Despite the name, it is not primarily a disease of ovarian cysts; the cysts are a consequence. At its core, PCOS is a disorder of androgen excess and insulin dysregulation (Dunaif, Endocrine Reviews, 1997).

Diagnosis (Rotterdam criteria) requires two of three: irregular or absent ovulation; clinical or biochemical hyperandrogenism; polycystic ovarian morphology on ultrasound. Scalp hair thinning in a female pattern is one of the recognized clinical signs of the hyperandrogenism.

The Androgen Cascade That Reaches Your Scalp

Elevated insulin sits upstream. Most women with PCOS have some degree of insulin resistance. Elevated insulin stimulates the ovaries to produce more androgens and reduces the liver's output of sex hormone-binding globulin (SHBG) — the protein that keeps testosterone bound and inactive in circulation. Less SHBG means more free testosterone reaching androgen-sensitive tissue (Dunaif, 1997).

At the follicle, testosterone becomes DHT via the enzyme 5-alpha reductase, and DHT binds follicle androgen receptors far more strongly than testosterone itself. In genetically susceptible scalp follicles, that signal progressively shortens each growth cycle and shrinks the follicle — each successive hair finer and shorter than the last. This is androgenetic (pattern) hair loss: in women, typically a widening central part and thinning crown with the frontal hairline preserved. The follicles where it happens are biochemically primed for it — frontal scalp follicles carry higher levels of 5-alpha reductase and androgen receptor than the occipital follicles that keep their hair (Sawaya & Price, JID, 1997).

And the cruel asymmetry: the same androgens stimulate terminal hair on the face, chin, and body while suppressing it on the scalp — different follicle populations, opposite responses, one hormone. Hirsutism and scalp thinning at the same time is not a contradiction; it is the same mechanism read in two directions.

What the Pharmaceutical Options Are — Stated Plainly

Because PCOS affects women of reproductive age, the drug options for its hair manifestations come with facts you deserve stated clearly, from their own labeling and guidelines:

Combined oral contraceptives suppress ovarian androgen production and raise SHBG. They are contraception — incompatible with trying to conceive — and carry their documented risk considerations, which your prescriber will weigh with you.
Spironolactone, used off-label as an androgen blocker, is contraindicated in pregnancy; reliable contraception is required during use.
Finasteride and dutasteride inhibit the enzymes that produce DHT. They are not approved for premenopausal women, and pregnancy exposure can harm a male fetus.
Metformin and GLP-1 medications address the metabolic side; hair effects are indirect.

These are real, legitimate tools in the right hands. But notice the pattern: for a population in which many women are actively trying to conceive, most of the direct-acting options are pregnancy-incompatible. That is the honest reason interest in non-drug approaches runs so high in PCOS — and here is our own line, stated with the same plainness: MD HAIR products are not drugs and do not do what these drugs do. They are drug-free products addressed to the same hair concern — and because there are no clinical data in pregnant or breastfeeding women, we do not advocate using our products during pregnancy or lactation either. If you are trying to conceive, that boundary applies to us too; build your plan with your physician.

The Drug-Free Layer: What Actually Has Evidence

1. The insulin-androgen axis — the highest-leverage target

Reducing insulin drive reduces ovarian androgen output and raises SHBG — addressing the cascade at its origin. The tools are unglamorous and real: dietary pattern, resistance and aerobic exercise, and weight management where appropriate, all endorsed as first-line in the international evidence-based PCOS guidelines. This is medical-nutritional territory to work through with your clinician — and it outranks anything sold in a bottle, ours included.

On inositol, the supplement most discussed for PCOS: a systematic review and meta-analysis conducted to inform the 2023 International PCOS Guideline found inositol reduced testosterone and improved some metabolic measures across randomized trials — while the guideline itself judges the overall evidence limited and inconclusive (Inositol for PCOS, JCEM, 2024). That is the honest state of it: promising signals, modest certainty, a conversation for your physician rather than a self-prescription.

2. Bloodwork before products

A proper workup tells you which drivers are actually yours: free and total testosterone, DHEA-S, SHBG, LH/FSH, fasting insulin and glucose, thyroid panel with antibodies (thyroid autoimmunity travels with PCOS), ferritin, vitamin D, and prolactin. Some "PCOS hair loss" turns out to be thyroid or iron — findable, fixable, and no supplement substitutes for finding it (Trost et al., JAAD, 2006).

3. The follicle's own cells — where our science sits

For the pattern-loss component itself, MD HAIR's approach runs through the follicle's signaling hub rather than a drug pathway. MD Nutri Hair™ leads with lilac stem-cell extract standardized for verbascoside — a compound studied in controlled laboratory work on human dermal papilla cells, where it induced cell proliferation, prevented testosterone-induced cell death at a statistically significant level, and reduced inflammatory signaling (Wisuitiprot et al., Scientific Reports, 2022). Cell studies, not human trials — we state the evidence at its weight. But note what the model was: follicle cells under testosterone stress. That is precisely the environment PCOS creates.

4. The scalp environment

An androgen-stimulated scalp often runs oilier, and a comfortable, balanced scalp surface is the foundation the rest sits on. MD® Scalp Essential — mandelic-acid renewal, caffeine, lilac stem-cell extract with CLA glutathione — keeps that foundation gently exfoliated, refreshed, and soothed-looking. A cosmetic doing a cosmetic's honest job.

The Emotional Reality

The simultaneous experience of unwanted facial hair and scalp thinning is, for many women, the sharpest assault PCOS makes on identity. It is not vanity to take it seriously — quality-of-life research in hair loss documents impact comparable to major skin disease (Williamson et al., JEADV, 2001). You are allowed to want both an honest medical plan and your hair.

The Bottom Line

PCOS hair loss runs through a defined chain — insulin, androgens, DHT, follicle miniaturization — and every link can be addressed at its own level: the metabolic root with your clinician; the diagnosis with proper bloodwork; the drug options with clear eyes about pregnancy compatibility; and the hair concern itself with a consistent, drug-free routine judged on photographs at 90 days and beyond. The paradox of PCOS hair is real. So is the path through it.

Dr. Susan Lin's Clinical Perspective

"PCOS is where I most often see women handed a prescription and no plan. The prescriptions are legitimate — but spironolactone and finasteride demand contraception, the pill is incompatible with conceiving, and many of my PCOS patients are trying to conceive. So the sequence I teach is different: metabolic work first, because insulin sits upstream of the androgens; complete bloodwork second, because thyroid disease and iron deficiency hide inside 'PCOS hair loss' more often than anyone expects; and then a consistent drug-free hair routine, judged at ninety days on photographs. And one boundary I hold for my own products as firmly as for anyone's drugs: there are no clinical data in pregnancy and lactation, so if you are pregnant or nursing, we don't advocate using them. A physician-founded brand should be the first to say that, not the last."

— Dr. Susan Lin, MD, Physician Formulator, MD HAIR

Mechanism Spotlight: Insulin Loads the Androgen Cascade

The distinctive feature of PCOS hair loss is that it starts far from the scalp. Hyperinsulinemia — present in most women with PCOS — acts twice: it stimulates ovarian theca cells to overproduce androgens, and it suppresses hepatic SHBG production, so a larger fraction of testosterone circulates free and bioactive (Dunaif, Endocrine Reviews, 1997). Free testosterone reaching the scalp is converted to DHT by 5-alpha reductase — an enzyme frontal follicles carry in greater quantity than the occipital follicles that resist pattern loss (Sawaya & Price, JID, 1997) — and DHT progressively miniaturizes susceptible follicles. This is why metabolic intervention is legitimate hair strategy in PCOS: reduce the insulin drive and you reduce the androgen load before it ever reaches the follicle. And it is why the laboratory evidence on verbascoside is relevant here: in human dermal papilla cells — the follicle's control center — verbascoside protected cells from testosterone-induced death signaling (Wisuitiprot et al., 2022); in-vitro evidence, aimed at exactly the stress PCOS applies.

MD HAIR Product Recommendation

MD Nutri Hair™ — Hair Density Supplement (90-day)

For the pattern component of PCOS-associated hair concerns, the rationale runs straight through the mechanism above: verbascoside's laboratory evidence was generated on follicle cells under testosterone stress — the PCOS environment in miniature. One capsule daily, no drugs, no hormones, judged at 90 days on photographs; pair with MD® Scalp Essential if your scalp runs oily or congested. If you are pregnant, nursing, or actively trying to conceive, hold off — per our own policy — and build the plan with your physician first.

→ Take the hair quiz

References (verified — click to check)

Educational content, not medical advice. Individual results vary. Consult your physician for personalized guidance. PCOS is a medical condition requiring medical management; MD HAIR products do not treat PCOS or any disease — they help address some of the hair and scalp concerns associated with it. Prescription medications are described from their labeling and clinical guidelines for informational purposes.

Pregnancy and breastfeeding: because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.

MD Nutri Hair™ is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Dr. Susan Lin, MD is the physician formulator behind MD HAIR, a line of drug-free hair products by La Cañada Ventures, Inc.